Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing benefits of the nucleus-annulus design of the M6-C disc LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the presentation of five-year data from the … [Read more…]

LIFEOLOGY® Radio Host James Miller Publishes LIFE LESSONS: You are the Expert on Your Life | A Workbook

A Collection of Practical Tools and Techniques for Daily Development FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–James Miller and LIFEOLOGY® | Publishing today announced the publication of LIFE LESSONS: You are the Expert on Your Life | A Workbook. “LIFE LESSONS is designed to help you focus on what already works for you,” James Miller says, “the book … [Read more…]

Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board

PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics. “We are pleased that Cuong has agreed to … [Read more…]

Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has filed a premarket approval supplement with the FDA for its fourth generation rechargeable sacral neuromodulation implantable neurostimulator (INS). The fourth generation rechargeable INS reduces how frequently a patient … [Read more…]

 TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies. Under the terms … [Read more…]

BioAge CEO to Lead a Panel Discussion at the BIO 2022 Conference: “Targeting Aging Pathways to Treat Chronic Disease” — June 14, 2022, 11 AM

Company CEO and CBO will be available throughout BIO 2022 for partnering meetings RICHMOND, Calif.–(BUSINESS WIRE)–BioAge Labs, Inc. (“BioAge”, “the Company”), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that Kristen Fortney, PhD, CEO and Co-Founder of BioAge, will lead a panel discussion at … [Read more…]

Chunghwa Telecom Co., Ltd. and Thonburi Hospital Collaborate to Create the New Chapter of Thailand’s “Smart Hospital” Services

TAIPEI, Taiwan–(BUSINESS WIRE)–On May 31st, 2022 Chunghwa Telecom Co., Ltd. (CHT) and Thonburi Hospital (TH) signed the “Smart Hospital” MOU. In light of the government of Thailand’s “Medical Hub of Asia” strategy in 2004, and its goal to become the leading Southeast Asian countries in providing international healthcare services, the two parties, CHT and TH, … [Read more…]

Global Oral Rehydration Salt Market Research Report 2022 – Featuring Abbott, Sanofi, Otsuka Pharmaceutical and AmJan Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Oral Rehydration Salt Market Research Report 2022 (Status and Outlook)” report has been added to ResearchAndMarkets.com’s offering. The Global Oral Rehydration Salt Market Size was estimated at USD 646.1 million in 2021 and is projected to reach USD 958.7 million by 2028, exhibiting a CAGR of 6.80% during the forecast period. The … [Read more…]

Global Mantle Cell Lymphoma Market to 2028 – Increasing Prevalence of MCL and Growth in Health Care Awareness to Benefit North America Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Mantle Cell Lymphoma Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028” report has been added to ResearchAndMarkets.com’s offering. According to a study published by Insure Insights, the global mantle cell lymphoma market is estimated to grow at a CAGR of 7.3% during the forecast period. Mantle cell lymphoma (MCL) … [Read more…]

Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna

− Moderna to become marketing authorization holder in Japan and be responsible for all import, local regulatory, development, quality assurance and commercial activities for Spikevax™ from 1st August 2022 − Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period. CAMBRIDGE, Mass. & … [Read more…]